Acute rhabdomyolysis associated with cerivastatin therapy

[1] AN OVERVIEW OF LIPID-LOWERING DRUGS [J]. DRUGS, 1988, 36 : 63 - 71

[2] PEDERSEN TR, 1994, LANCET, V344, P1383

[3] Extending therapy options in treating lipid disorders - A clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor [J]. DRUGS, 1998, 56 (Suppl 1) : 25 - 31

[4] Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) : 11J - 17J

[5] HMG COA REDUCTASE INHIBITORS - CURRENT CLINICAL-EXPERIENCE [J]. DRUGS, 1988, 36 : 83 - 86

[1] AN OVERVIEW OF LIPID-LOWERING DRUGS [J]. DRUGS, 1988, 36 : 63 - 71

[2] PEDERSEN TR, 1994, LANCET, V344, P1383

[3] Extending therapy options in treating lipid disorders - A clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor [J]. DRUGS, 1998, 56 (Suppl 1) : 25 - 31

[4] Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) : 11J - 17J

[5] HMG COA REDUCTASE INHIBITORS - CURRENT CLINICAL-EXPERIENCE [J]. DRUGS, 1988, 36 : 83 - 86